Thermo Fisher Scientific Derivative Liability increased by 18.2% to $598.00M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in liabilities may indicate unfavorable market movements against the firm's hedges or increased hedging activity.
This represents the total fair value of all derivative contracts that are in a loss position for the company at the repo...
Standard metric for any large financial institution or insurer with significant balance sheet hedging activities.
other_derivative_liabilities| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $506.00M | $598.00M |
| QoQ Change | — | +18.2% |